期刊文献+

氧化/抗氧化失衡在COPD稳定期慢性肺损伤的机制研究 被引量:9

Mechanism research on oxidation/anti-oxidation imbalance in patients with chronic lung scathing of chronic obstructive pulmonary disease at stable stage
暂未订购
导出
摘要 目的探讨稳定期不同级别COPD患者血清中氧化/抗氧化因子及细胞炎症因子水平与肺功能主要指标的关系。方法选取COPD稳定期患者80例,检测各患者肺功能与血清中反应性氧核素(ROS)、超氧化物歧化酶(SOD)及细胞炎症因子水平,观测各组的差异并分析其相关性。结果 FEV1、FVC、FEV1/FVC、SOD、ROS、TNF-α、IL-8、GM-CSF水平在不同组别中存在差异(P<0.05),ROS、TNF-α、IL-8、GM-CSF水平与FEV1,FVC、FEV1/FVC存在着明显的负相关(P<0.05),SOD与其存在明显正相关(P<0.05)。结论 COPD细胞炎症因子的持续升高及氧化加重可能是引起稳定期COPD肺组织慢性损伤、功能降低的重要机制。 Objective To explore the relationship of serum oxidation/anti-oxidation and the level of inflammatory eytokines to pulmonary functions in patients with COPD at stable stage. Methods 80 COPD patients at stable stage were divided into I degree, Ⅱ degree, m degree and Ⅳ degree Group based on GOLD grading standard. The pulmonary function and the levels of ROS, SOD and inflammatory cytokines in serum were detected and analyzed. Results The levels of FEV1 , FVC, FEV1/FVC, SOD, ROS, TNF-a, IL-8 and GM-CSF were significantly different in the different degrees ( P 〈0. 05 ). The levels of ROS, TNF-A, IL-8, and GM-CSF were negatively correlated with that of FEV1 and FVC, but SOD were positively correlated with lung function. Conclusion The continuous increase of inflammatory cytokines and the exacerbation of oxidation may be the causes of chronic damage in pulmonary tissues and decrease of pul- monary function in COPD patients at stable phase.
出处 《临床肺科杂志》 2013年第2期238-240,共3页 Journal of Clinical Pulmonary Medicine
基金 上海市建工集团科研基金项目(编号:2009-100)
关键词 COPD 稳定期 呼吸功能 ROS SOD FVC FEV1 TNF-α IL-8 GM-CSF COPD stable stage respiratory function ROS SOD FVC FEV1 TNF-a IL-8 GM-CSF
  • 相关文献

参考文献7

  • 1Rabe KF, Wedzicha JA. Controversies in treatment of chronic ob-structive pulmonary disease [ J]. Lancet,2011,10; 378 ( 9795 ):1038 -47.
  • 2Rennard SI. The role of free radical oxidation and endothelial dys-function in the onset and progression of chronic obstructive pulmona-ry disease[ J] . Ter Arkh,2011,83(3) :74 -7.
  • 3Martinez FJ, Donohue JF, Rennard SI. The future of chronic ob-structive pulmonary disease treatment-difficulties of and barriers todrug development[J]. Lancet, 2011,10;378(9795) :1027 -37.
  • 4杨孔军,吴丹丹.COPD气道重塑相关机制的研究进展[J].临床肺科杂志,2012,17(3):510-512. 被引量:31
  • 5van Eeden SF, Hogg JC. Chronic obstructive pulmonary disease : doregional differences in tissue inflammation matter[ J] . Respiration,2011,81(5):359 -61.
  • 6Brusselle GG, Joos GF,Bracke KR. New insights into the immu-nology of chronic obstructive pulmonary disease [ J]. Lancet, 2011 ,10;378(9795) :1015-26.
  • 7颜雪琴,金玲湘,戴元荣.慢性阻塞性肺疾病急性加重期细胞因子测定的意义[J].临床肺科杂志,2007,12(3):224-225. 被引量:32

二级参考文献23

  • 1刘景艳,修清玉.细胞因子在慢性阻塞性肺疾病发病中的作用[J].国外医学(呼吸系统分册),2005,25(6):420-422. 被引量:95
  • 2黎东明,陈琼,何惠娟,蔡康荣,岑慧.慢性阻塞性肺疾病发病中的中性粒细胞凋亡作用研究[J].中国基层医药,2005,12(5):517-519. 被引量:17
  • 3吴纪珍,马利军,李素云,牛红丽.慢性阻塞性肺疾病发作期与缓解期体内胶原、细胞因子变化及临床意义[J].中国实用内科杂志,2005,25(8):703-704. 被引量:38
  • 4Chung KF.The role of airway smooth muscle in the pathogenesis of airway wall remodeling in chronic obstructive pulmonary disease[J].Proc Am Thorac Soc,2005,2(4):347-54 ; discussion 371-2.
  • 5Postma DS,Timens W.Remodeling in asthma and chronic obstructive pulmonary disease[J].Proc Am Thorac Soc,2006,3(5):434-9.
  • 6Chapman HA.Disorders of lung matrix remodeling[J].J Clin Invest,2004,113(2):148-57.
  • 7Oltmanns U,Sukkar MB,Xie S,et al.Induction of human airway smooth muscle apoptosis by neutrophils and neutrophil elastase[J].Am J Respir Cell Mol Biol,2005,32(4):334-41.
  • 8Lapperre TS,Willems LN,Timens W,et al.Small airways dysfunc tion and neutrophilic inflammation in bronchial biopsies and BAL in COPD[J].Chest,2007,131(1):53-9.
  • 9Chung KF.Inflammatory mediators in chronic obstructive pulmonary disease[J].Curr Drug Targets Inflamm Allergy,2005,4(6):619-25.
  • 10Chung KF.Cytokines as targets in chronic obstructive pulmonary disease[J].Curr Drug Targets,2006,7(6):675-81.

共引文献61

同被引文献110

引证文献9

二级引证文献173

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部